Schonfeld Strategic Advisors LLC Enovis Corp Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$55.44 - $63.8 $2.46 Million - $2.83 Million	-44,345 Reduced 90.47%	4,673 $291,000
Q4 2023 Feb 14, 2024	BUY	$43.67 - $57.07 $2.14 Million - $2.8 Million	49,018 New	49,018 $2.75 Million
Q2 2023 Aug 14, 2023	SELL	$52.7 - $64.12 $119,945 - $145,937	-2,276 Reduced 38.95%	3,568 $228,000
Q1 2023 May 15, 2023	BUY	$49.5 - $65.92 $8,266 - $11,008	167 Added 2.94%	5,844 $312,000
Q4 2022 Feb 14, 2023	SELL	$44.83 - $57.43 $1.01 Million - $1.29 Million	-22,456 Reduced 79.82%	5,677 $303,000
Q3 2022 Nov 14, 2022	BUY	$46.07 - $60.1 $1.3 Million - $1.69 Million	28,133 New	28,133 $1.3 Million

315

60.5M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.52B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.